[HTML][HTML] A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
…, E Muñez-Rubio, B Ruiz-Antorán… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán… - Journal of …, 2017 - Elsevier
Background & Aims Clinical trials evaluating second-generation direct-acting antiviral agents
(DAAs) have shown excellent rates of sustained virologic response (SVR) and good safety …
(DAAs) have shown excellent rates of sustained virologic response (SVR) and good safety …
A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality
A Fernández-Cruz, B Ruiz-Antorán… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia
is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on …
is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
[HTML][HTML] Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study
B Ruiz-Antorán, A Sancho-López, F Torres… - Infectious diseases and …, 2021 - Springer
Background We aimed to determine the impact of tocilizumab use on severe COVID-19 (coronavirus
disease 19) pneumonia mortality. Methods We performed a multicentre …
disease 19) pneumonia mortality. Methods We performed a multicentre …
[HTML][HTML] Efficacy and safety of sarilumab in patients with COVID19 pneumonia: a randomized, phase III clinical trial (SARTRE study)
…, AF Caballero-Bermejo, B Ruiz-Antorán… - Infectious diseases and …, 2021 - Springer
Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…
Convalescent plasma for COVID-19: a multicenter, randomized clinical trial
…, A Ramos-Martinez, E Munez-Rubio, B Ruiz-Antoran… - MedRxiv, 2020 - medrxiv.org
Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …
Cervical pessary compared with vaginal progesterone for preventing early preterm birth: a randomized controlled trial
…, C Martinez-Payo, B Ruiz-Antorán… - Obstetrics & …, 2018 - journals.lww.com
OBJECTIVE: To compare the effectiveness of a cervical pessary and vaginal progesterone to
prevent spontaneous preterm births in pregnant women with cervical lengths 25 mm or less …
prevent spontaneous preterm births in pregnant women with cervical lengths 25 mm or less …
Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: a retrospective controlled cohort study
A Fernández Cruz, B Ruiz-Antoran, AM Gómez… - medRxiv, 2020 - medrxiv.org
Objective We aim to determine the impact of steroid use in COVID-19 pneumonia in-hospital
mortality. Design We performed a single-centre retrospective cohort study. Setting A …
mortality. Design We performed a single-centre retrospective cohort study. Setting A …
Real-world effectiveness and safety of oral combination antiviral therapy for hepatitis C virus genotype 4 infection
…, I Fernández, B Sacristan, B Ruiz-Antorán… - Clinical …, 2017 - Elsevier
Patients with hepatitis C virus (HCV) genotype 4 infection are poorly represented in clinical
trials of second-generation direct-acting antiviral agents (DAAs). More data are needed to …
trials of second-generation direct-acting antiviral agents (DAAs). More data are needed to …